|
|
| |
| |
 |
Technical Board
|
 |
| Dr. Bill Piu CHAN, MD |
top |
Dr. Chan is currently Professor and Director of the Beijing Institute of Geriatrics and a member of American Academy of Neurology. He has been appointed as the Deputy Director and Principal Investigator of Chinese National Human Genome Center Beijing since 2001. He is the Vice President of the Chinese Society of Gerontology and Geriatrics, council member of the International Association of Gerontology and Geriatrics (IAGG), and Secretary of the IAGG Asia-Oceania Region. He was the President of the Society of Chinese Neuroscientists in America from 1998 to 2000 and the Secretary of Asia-Pacific Society for Neurochemistry from 2000 to 2006. In 2002, he attained First Award for Scientific Achievement from both Ministry of Education and Chinese Medical Association in China.
Dr. Chan graduated from Human Medical College in Changsha and became a neurologist after the fellowship training. He later acquired his PhD on neurosciences from Sun Yan-Sen University of Medical Sciences in Guangzhou followed by postdoctoral training at the Parkinson's Institute in Sunnyvale, California of USA where he spent more than 10 years as senior scientist before returned back to China. Dr. Chan is well known for his clinical and basic research on Parkinson’s disease and geriatric disorders. |
|
Dr. Chen is now Professor of Department of Cell Biology and Genetics, College of Life Sciences, Peking University. |
|
| Dr. Royston Frederick DRUCKER, MD |
top |
Dr. Drucker obtained a physician qualification from Cambridge University. He is a founder and honorary member of the Association for Human Pharmacology in the Pharmaceutical Industry, a fellow of the Royal Society of Medicine, and a member of the Securities Institute. After a career of 8 years in clinical practice, he joined the research and development division of Sterling-Winthrop Limited as senior departmental manager of the Department of Biochemistry. Later he was appointed European Head of clinical pharmacology, Executive Director and subsequently Corporate Vice President of drug development at the Upjohn Company in the U.S. From 1996 to 2005, he was General Manager of Technomark Consulting Services Limited. He is now the Medical Director of e-Therapeutics, responsible for organizing and supervising clinical trials for drug candidates of the company. He also serves in the Technical Board of Obio. |
|
Dr. Thoene attended his undergraduate program majoring in Chemistry at Stanford University and furthered his studies at the medical school of Johns Hopkins University. His pediatric residency was in the Harriet Lane Home Pediatric program. He also completed a 3-year fellowship in metabolic genetic disease at the University of California, San Diego. Dr. Thoene is a member of the American Society of Clinical Investigation and the American Pediatrics Society. From 1988-89, he served as the Chairman of the National Commission of Orphan Diseases and the Chairman of the Board of the National Organization for Rare Disorders. From 2000-2006 he served as the Karen Gore Professor of Pediatrics, Director of the Hayward Genetics Center and Human Genetics Program at Tulane University Health Sciences Center. He is currently Active Professor Emeritus at the University of Michigan In the Division of Pediatric Genetics. |
|
|
|
|
